This article first appeared on GuruFocus .
Release Date: July 24, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
SGS AG ( SGSOF ) reported strong organic growth of 5.6% in the first half of 2026, with potential to exceed 6% without the Middle East crisis impact.
-
The company's digital trust segment experienced a remarkable 38% growth, driven by wireless-connected devices and recent acquisitions.
-
Sustainability initiatives, particularly the Impact Now program, delivered strong results with 18% total growth.
-
The acquisition of Granite River Laboratories and other bolt-on acquisitions have contributed significantly to the company's growth and capabilities.
-
SGS AG ( SGSOF ) achieved an improved adjusted operating income margin of 15.1%, reflecting effective cost management and operational efficiencies.
Negative Points
-
The ongoing crisis in the Middle East has negatively impacted the company's organic growth and margins, particularly in the industries and environment segment.
-
Despite strong performance in several areas, the company faced challenges in Europe with soft volumes in natural resources and connectivity and products.
-
The company's net debt has increased significantly to EUR 3.9 billion, raising concerns about financial leverage.
-
Restructuring costs related to the Middle East situation are expected to reach around CHF 30 million for the year.
-
The strong Swiss franc has resulted in a negative translation impact of 5.8% on the company's financial results.
Q & A Highlights
Q: Can you discuss the margin impact of scope changes, particularly regarding ATS and Business Assurance? A: (Geraldine Picot, CEO) We are pleased with ATS's performance in both sales and margins. The synergies in cross-selling and cost are developing well, making ATS slightly accretive to our margins. (Marta Vlachkova, CFO) The $98 million figure refers to EBITDA, not adjusted operating income. The Middle East situation has impacted margins in Industry and Environment, but ATS's margin is slightly above our average in this segment.
Q: How have acquisitions impacted unbilled sales and WIP numbers, and how is ATS's growth treated? A: (Geraldine Picot, CEO) ATS is fully on the scope for one year since it was closed in January, impacting our scope but not organic growth. (Marta Vlachkova, CFO) Unbilled revenue is affected by ATS and other acquisitions, ForEx impacts, and seasonal contract billing, which is typical in the first half.
Q: What are your expectations for restructuring charges this year, considering the Middle East conflict? A: (Geraldine Picot, CEO) We need to adjust costs due to reduced revenue in the Middle East. (Marta Vlachkova, CFO) We incurred $18 million in restructuring costs in H1 and expect around $30 million for the full year, within our initial guidance of $20 to $40 million.
Q: Can you elaborate on the organic growth in North America and the drivers behind it? A: (Geraldine Picot, CEO) North America shows positive momentum, especially in Industry and Environment, with strong demand in non-destructive testing and energy sectors. Health and Nutrition also sees double-digit growth, particularly in food and pharma, driven by reshoring efforts and manufacturing expansion.
Q: How do you see growth progressing into the second half, and what's driving the acceleration in natural resources growth? A: (Geraldine Picot, CEO) We aim to maintain our current growth and margin trends. Natural resources growth is driven by strong minerals activity, despite softer agriculture and oil, gas, and chemicals due to the Middle East impact. Overall, we see continued momentum.
Q: Can you explain the organic growth in Europe and the impact of hyperinflation in LATAM? A: (Geraldine Picot, CEO) Europe sees high single-digit growth in food and new projects in industries and environment, but faces softness in pharma and natural resources. (Marta Vlachkova, CFO) In LATAM, hyperinflation in Argentina is excluded from organic growth calculations, ensuring the 9% growth is not inflated.
Q: Will the growth in cosmetics and personal care continue in the second half, and what are the cost synergies achieved with ATS? A: (Geraldine Picot, CEO) Yes, we expect higher growth in cosmetics due to project wins. We are on track with ATS synergies, expecting at least $5 million in cost synergies this year, with initiatives like cross-selling in data centers.
Q: How do you view the evolution of your portfolio with recent M&A activity, and what is the growth contribution of Business Assurance components? A: (Geraldine Picot, CEO) We will continue bolt-on acquisitions as they create shareholder value. Integration varies by acquisition type. Business Assurance growth is driven by digital, food, and medical devices, with core ISO certification growing low to mid-single digits.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
